Skip to main content
. 2024 Aug 16;49:100843. doi: 10.1016/j.ctro.2024.100843

Fig. 1.

Fig. 1

Oncologic outcomes by treatment type: (a) cumulative incidence of biochemical failure; (b) Kaplan-Meier of metastasis-free survival; (c) cumulative incidence of castrate-resistant prostate cancer; (d) Kaplan-Meier of prostate cancer specific survival; and (e) Kaplan-Meier of overall survival.